Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of tauopathies with mGluR5 antagonists

Treatment of tauopathies with mGluR5 antagonists

US Patent 10335400 · Granted Jul 2, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of tauopathies by passive immunization targeting the N-terminal projec2019
Neurogenic brain-derived neurotrophic factor peptides2018
Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide 2017
Neurogenic brain-derived neurotrophic factor peptides2016
Neurotrophic peptides for the treatment of tauopathies2016
Treatment of brain injury with a neurotrophic peptide2016
Neurotrophic peptides2014
Neurotrophic peptides2014
Neurotrophic peptides2013
Method for evaluating blood-neural barrier permeability2013
Neurotrophic peptides2012
Alkylation system with catalyst transfer2011